Public
ºÚÁÏÕýÄÜÁ¿ Association content that is available to the public and all website users.
January 31, 2023
April Tabor
Secretary Federal Trade Commission
600 Pennsylvania Avenue NW
Suite CC-5610 (Annex C)
Washington, DC 20580
Re: Notice of Proposed Rulemaking, Federal Trade Commission; Non-Compete Clause Rule; 88 Fed. Reg. 3482 (RIN: 3084-AB74) (January 19, 2023)
Dear Ms. Tabor:
Executive Summary
Three vulnerabilities were identified in an older version of OpenEMR, a popular electronic health records system, which can allow for a cyberattacker to access sensitive information and even compromise the entire system. The prevalence of ransomware attacks and data breaches…
Health-ISAC, in coordination with HC3, is sharing the following report on OpenEMR Sector Alert.
Drugmakers that participate in the 340B drug pricing program do not have to provide discounted 340B drugs to an unlimited number of contract pharmacies, the U.S. Court of Appeals for the 3rd Circuit ruled in Sanofi-Aventis U.S. v. HHS et al.
AHA comments on the CMS’ Request for Information on Essential Health Benefits (EHB).
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
The hacktivist group ‘KillNet’—has targeted the U.S. healthcare industry in the past and is actively targeting the health and public health sector.
AHA provides feedback to the Senate on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform.
On this Leadership Dialogue Series podcast, two chairs of the ºÚÁÏÕýÄÜÁ¿ Association’s Board of Trustees come together to share their insights on the state of health care in our country, and what hospitals and health systems can look forward to in 2023.
AHA provides feedback on the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, and to support Congress’ continued efforts to transform health care through permanent telehealth reform